Temedica’s Post

We're excited to share our Day 1 insights from the World Evidence, Pricing and Access Congress, happening right here in Amsterdam. This event has proven to be an incredible hub of knowledge and innovation, gathering over 1500 attendees from the Pharma, Biotech sectors. This congress is laser-focused on the most current trends in market access, pricing, evidence, and the increasingly critical field of health economics and outcomes research (HEOR). For those of us in commercial operations within the Pharma or Medtech sectors, staying ahead of the curve is not just an option but a necessity. Today, we've had the opportunity to dive deep into discussions around key strategies, market outlooks, and innovative approaches that are shaping our industry. The focus on real-world evidence (RWE), innovative models, and the latest in reimbursement strategies has been particularly enlightening. Vamstar stands at the forefront, illuminating the path for teams eager to leverage market data for unparalleled efficiency. Our robust suite of capabilities is designed to empower you to make data-driven decisions that not only anticipate market shifts but also respond to them with agility and confidence. As we navigate through the complexities of market access, pricing, and evidence, it's clear that the ability to adapt and innovate is more critical than ever. Whether it's discussing the latest in health economics, exploring new payment models, or understanding the impact of digital transformation on our industry, Vamstar is here to ensure that your team is equipped with the knowledge and tools to lead and succeed. If you or your team are on site and would like to learn more on how Vamstar can support your commercial endeavours with AI, please take a moment to book a meeting using the link in the description! Let's continue to engage, learn, and drive forward the future of healthcare together. #WorldEPACongress2024 #HealthEconomics #MarketAccess #Pharma #Medtech

We're thrilled to announce the global themes for the RWEsearch Annual Summit 2024 Virtual Annual Summit 2024! This year, we're bringing together leading experts and industry innovators to explore the latest advancements and transformative trends in: The RWEsearch Lens on #ChangingMarkets: Dive into the dynamic landscape of healthcare markets and discover how real-world evidence (#RWE) is shaping market access, pricing, and regulatory strategies. The RWEsearch Lens on #Patients: Focus on patient-centric approaches, from identifying patient populations to understanding patient journeys and improving outcomes with RWE. The RWEsearch Lens on #AdvancedDataSources: Uncover the power of advanced data sources and analytics in generating actionable insights, enhancing decision-making, and driving innovation in #healthcare. The RWEsearch Lens on #ClinicalTrials: Explore the integration of RWE in clinical trial design, execution, and post-market surveillance, and learn how it is revolutionizing the clinical development process. Join us for this groundbreaking event to gain unparalleled insights, network with thought leaders, and stay ahead of the curve in the rapidly evolving world of healthcare. Register on the link below: https://lnkd.in/eMditMke Stay tuned for more updates and exciting announcements as we gear up for an unforgettable summit! #RWEsearch2024 #HealtharkInsights #ClinicalTrials #AdvancedData #ChangingMarkets #PatientCare #VirtualSummit

Today I’ve attended the 100th birthday event by Roche on "Closing the healthcare gap" A few key takeaways to start the weekend: 1️⃣ Every 15 years, Roche adapts its entire portfolio to drive innovation and effectively bring it to patients. Research and innovation are vital in this process. 2️⃣ Collaboration is essential to bridge the silos between pharma and prevention, ensuring faster access to medicine and healthcare advancements. 🤝 3️⃣ With 50% of the world lacking basic healthcare access, the importance of prevention cannot be overstated. Involving the patient perspective early on and adopting technology are crucial steps forward. 4️⃣ Early diagnostics and data utilization hold the key to unlocking the full potential of healthcare, leading to improved clinical outcomes and cost benefits. 📊💉 5️⃣ Empowering patients with data ownership is pivotal in advancing healthcare delivery. These insights underscore the urgency to prioritize innovation, embrace prevention, harness the power of data, and foster collaboration for a more equitable healthcare landscape. Thank you for hosting this interesting morning Isabelle Decker Marie-José Borst #HealthcareInnovation #ClosingTheGap

J.P. Morgan Global Healthcare Conference 8th to 11th January 2024: What are the Key Talking Points likely to be? The J.P. Morgan Global Healthcare Conference is one of the most prestigious healthcare conferences in the world. It is attended by thousands of investors, analysts, and healthcare executives from around the globe. The conference provides a platform for companies to present their latest developments and strategies to investors. The 2024 J.P. Morgan Global Healthcare Conference will likely focus on a number of key trends and topics, including: > The Future of Drug Discovery and Development: The pharmaceutical industry is undergoing a major transformation, with new technologies such as artificial intelligence (AI) and machine learning (ML) playing an increasingly important role in drug discovery and development. The conference is likely to feature discussions on the latest trends in drug discovery and development, as well as the impact of new technologies on the industry. > The rise of Personalised Medicine: Personalised medicine is an approach to healthcare that takes into account individual genetic, environmental, and lifestyle factors to provide the best possible care for each patient. The conference is likely to feature discussions on the latest advances in personalised medicine, as well as the challenges and opportunities of implementing personalised medicine on a large scale. > The Impact of Digital Health: Digital health technologies are transforming the way healthcare is delivered. The conference is likely to feature discussions on the latest digital health trends, as well as the impact of digital health on the pharmaceutical industry and the overall healthcare system. > The Global Healthcare Landscape: The global healthcare landscape is changing rapiply, with new challenges and opportunities emerging in different parts of the world. The conference is likely to feature discussions on the key trends and developments in different regions, as well as the implications for the pharmaceutical industry. > The Increasing Role of the Consumer in Healthcare: Consumers are playing an increasingly active role in their own healthcare. The conference is likely to feature discussions on the latest trends in consumer-centered healthcare, such as the use of wearable devices and telemedicine. > The Impact of Artificial Intelligence on Healthcare: Artificial intelligence is having a major impact on many industries, including healthcare. The conference is likely to feature discussions on the latest trends in AI in healthcare, such as the use of AI to develop new drugs and therapies and to improve the efficiency of healthcare delivery. #HealthTech #HealthIT #DigitalHealth #lloydgprice #NelsonAdvisors https://lnkd.in/e6YJrDnQ

So many in pharma and biotech talk about being patient centric, but let’s be honest - it’s often lip service. And honestly, what does “patient centric” even mean in practice? I’ll be speaking on a virtual panel for BHBIA delving into this.

A couple of days on from Patients as Partners and what has really stuck with me are three key takeaways: The importance of measuring the impact of patient engagement, we have to prove this stuff works (there are still naysayers), if we are to truly implement long term change in the industry. Zack Pemberton-Whiteley spoke about this in the Impact measurement framework that Novartis have implemented. Bringing the patient in early on is critical, only then can we design studies that have meaningful patient led endpoints. Lea-Isabelle Proulx summarised this nicely, we have to be patient-centric not science-centric in how we design our protocols. We need to start treating designing the patient experience as a hard science, on a par with the molecule design. DE&I continues to be a hugely important topic, and one that should be at the forefront of every initiative. The panel led by Dr Heidi Green , discussing the 4 myths around DE&I was superb, and great to hear from Robina Weermeijer on what companies like Boehringer are doing here. Thanks to all the amazing speakers and patient advocates that made another great event. April Campbell (née. Veasey) Victoria Wright Sarah McKeown-Cannon #PatientEngagement #ClinicalTrials #PatientsEU2024

J.P. Morgan Global Healthcare Conference January 2024: What are the key talking points likely to be? The J.P. Morgan Global Healthcare Conference 2024 is a major event in the healthcare industry, and it is likely to cover a wide range of topics. However, based on the current trends in the industry, here are some of the key talking points that are likely to be discussed at the conference: > Precision medicine: Precision medicine is a new approach to healthcare that uses genetic and molecular information to tailor treatments to individual patients. This is a rapidly growing field with the potential to revolutionize the way we treat diseases. > Data and analytics: Data and analytics are playing an increasingly important role in the healthcare industry. Companies are using data to develop new drugs and treatments, improve patient care, and reduce costs. > Consumer health: Consumer health is another growing trend in the healthcare industry. Consumers are becoming more proactive about their health and are looking for ways to stay healthy and manage chronic conditions. > Value-based care: Value-based care is a new model of healthcare that focuses on providing high-quality care at a lower cost. This is a top priority for healthcare payers, and it is likely to be a major topic of discussion at the conference. > Emerging technologies: There are a number of emerging technologies that are having a major impact on the healthcare industry. These technologies include artificial intelligence, machine learning, and blockchain. In addition to these broad topics, the conference is also likely to feature discussions on specific areas of healthcare, such as oncology, cardiology, and neurology. There will also be presentations from leading healthcare companies, investors, and analysts. #HealthTech #HealthIT #DigitalHealth #lloydgprice #NelsonAdvisors https://lnkd.in/e6YJrDnQ

J.P. Morgan Global Healthcare Conference January 8th to 11th 2024: What are the Key Talking Points likely to be? The 2024 J.P. Morgan Global Healthcare Conference will likely focus on a number of key trends and topics, including: > The future of drug discovery and development: The pharmaceutical industry is undergoing a major transformation, with new technologies such as artificial intelligence (AI) and machine learning (ML) playing an increasingly important role in drug discovery and development. The conference is likely to feature discussions on the latest trends in drug discovery and development, as well as the impact of new technologies on the industry. > The rise of personalised medicine: Personalised medicine is an approach to healthcare that takes into account individual genetic, environmental, and lifestyle factors to provide the best possible care for each patient. The conference is likely to feature discussions on the latest advances in personalised medicine, as well as the challenges and opportunities of implementing personalised medicine on a large scale. > The impact of digital health: Digital health technologies are transforming the way healthcare is delivered. The conference is likely to feature discussions on the latest digital health trends, as well as the impact of digital health on the pharmaceutical industry and the overall healthcare system. > The global healthcare landscape: The global healthcare landscape is changing rapidly, with new challenges and opportunities emerging in different parts of the world. The conference is likely to feature discussions on the key trends and developments in different regions, as well as the implications for the pharmaceutical industry. > The increasing role of the consumer in healthcare: Consumers are playing an increasingly active role in their own healthcare. The conference is likely to feature discussions on the latest trends in consumer-centered healthcare, such as the use of wearable devices and telemedicine. > The impact of artificial intelligence on healthcare: Artificial intelligence is having a major impact on many industries, including healthcare. The conference is likely to feature discussions on the latest trends in AI in healthcare, such as the use of AI to develop new drugs and therapies and to improve the efficiency of healthcare delivery. #HealthTech #HealthIT #DigitalHealth #lloydgprice #NelsonAdvisors https://lnkd.in/e6YJrDnQ

Alongside other industry leaders, we are pleased to partner with Digital Medicine Society (DiMe) to present at “Opportunities - and realities - of developing a multi-market DHT evidence and commercial approach in Europe”, a Partner Program at HLTH Europe on Mon., 17 June, from 2-4 p.m. CEST Miguel Amador from Complear will join this panel on the topic of:  Analyzing gaps within international regulatory and product assessment pathways Few companies aim to develop a single-market evidence and commercial approach within Europe. Yet, the challenges of developing a multi-market strategy continue to abound. Without the necessary resources and insights, digital health technologies (DHT) companies will be prevented from scaling across markets to serve patients across Europe. Experts from DiMe’s International Digital Health Regulatory Pathways initiative will lead a series of discussions centered on existing market landscapes, real-world case study experience, and long-term implications for DHT companies and policymakers. Join us to hear what is both realistic and possible in achieving commercialization and patient access. We’ll also share the actions DHT developers should take right now in Europe. Register now and save €150 with code: HE24_Digital150

Explore the 24 key takeaways from Frontiers Health 👇🏼